Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
In Japan, price revisions, growth in higher-value-added products, an improved product mix and the reorganization of the production structure contributed positively, while lower sales volume and higher costs for raw materials, energy, logistics and labor affected results. Overseas, higher selling prices resulting from rising whey protein market prices at MILEI GmbH, as well as expanded sales of bacterial cultures and infant formula, contributed to higher revenue and profit.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥147,099 million (YoY +2.4%) |
| Operating profit | ¥9,977 million (YoY +12.9%) |
| Ordinary income | ¥10,607 million (YoY +11.3%) |
| Profit attributable to owners of the parent | ¥6,678 million (YoY -3.4%) |
| Net income per share | ¥20.69 |
| Equity ratio | End of the current fiscal period 48.3％ / End of previous period 50.2％ |
| Total assets | ¥573,250 million |
| Net assets | ¥282,023 million |
| Full-year earnings forecast | Net Sales ¥580,000 million (YoY +1.5%) / Operating profit ¥34,000 million (YoY -1.4%) / Ordinary income ¥35,000 million (YoY -5.7%) / Net income ¥21,000 million (YoY -7.1%) |
| Revision to Earnings Forecast | Not disclosed → Net Sales 580,000 / Operating profit 34,000 / Ordinary income 35,000 / Net income 21,000 |
| Annual Dividend Forecast | ¥100.00 (actual for FY2026, before the stock split) → ¥25.00 (forecast for FY2027, after the stock split)（0.0% (after adjustment for the stock split)） |
| Payout ratio | 40% (target) |
| Shareholder Return Policy | Target payout ratio of 40%; flexible share repurchases will be carried out as appropriate. |
| Segment revenue | Segment Food / Net Sales ¥140,687 million (YoY +1.9%), Segment Other / Net Sales ¥6,411 million (YoY +14.4%) |
| Segment profit | Segment Food / Segment profit ¥12,841 million (YoY +9.6%), Segment Other / Segment profit ¥884 million (YoY +7.4%) |
| Depreciation and amortization | ¥6,405 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥3 million, Gain on business transfer ¥700 million, Other ¥180 million / Extraordinary loss Losses on disposal of fixed assets ¥178 million, Contribution to Hikari Association ¥460 million, Other ¥382 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Held (対象者：Not disclosed) |
| Issued Shares at Period-End | 344,719,144 Shares |
| Treasury Shares at Period-End | 21,923,908 Shares |
| Factors Behind Changes in Business Performance | In Japan, price revisions, growth in higher-value-added products, an improved product mix and the reorganization of the production structure contributed positively, while lower sales volume and higher costs for raw materials, energy, logistics and labor affected results. Overseas, higher selling prices resulting from rising whey protein market prices at MILEI GmbH, as well as expanded sales of bacterial cultures and infant formula, contributed to higher revenue and profit. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Price revisions, growth in higher-value-added products, an improved product mix and cost controls resulting from the reorganization of the production structure contributed to higher profit, while lower sales volume and rising costs for raw materials, energy, logistics and labor affected results. Overseas, higher selling prices resulting from rising whey protein market prices at MILEI GmbH, as well as expanded sales of bacterial cultures and infant formula, contributed to higher revenue and profit.